19-51645823-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001098612.3(SIGLEC14):c.659C>T(p.Ala220Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000111 in 1,529,614 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001098612.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SIGLEC14 | NM_001098612.3 | c.659C>T | p.Ala220Val | missense_variant | 3/7 | ENST00000360844.7 | NP_001092082.1 | |
SIGLEC14 | XM_047437991.1 | c.659C>T | p.Ala220Val | missense_variant | 3/5 | XP_047293947.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SIGLEC14 | ENST00000360844.7 | c.659C>T | p.Ala220Val | missense_variant | 3/7 | 1 | NM_001098612.3 | ENSP00000354090 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000744 AC: 1AN: 134494Hom.: 0 Cov.: 20
GnomAD3 exomes AF: 0.00000428 AC: 1AN: 233562Hom.: 0 AF XY: 0.00000792 AC XY: 1AN XY: 126216
GnomAD4 exome AF: 0.0000115 AC: 16AN: 1395120Hom.: 2 Cov.: 34 AF XY: 0.0000115 AC XY: 8AN XY: 693324
GnomAD4 genome AF: 0.00000744 AC: 1AN: 134494Hom.: 0 Cov.: 20 AF XY: 0.00 AC XY: 0AN XY: 64866
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 23, 2024 | The c.659C>T (p.A220V) alteration is located in exon 3 (coding exon 3) of the SIGLEC14 gene. This alteration results from a C to T substitution at nucleotide position 659, causing the alanine (A) at amino acid position 220 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at